SCHEMBL15715568

SCHEMBL15715568

COc1cccc(OC)c1-c1ccccc1[P@@](=O)(CF)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.56
▸ KMT2A Q03164 4/20 0.56
▸ HTT P42858 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ TOP1 P11387 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ MAPT P10636 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ DUSP3 P51452 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ CA2 P00918 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ PDK2 Q15119 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15715540 0.85 KMT2A (0.69) MEN1KMT2AHTTL3MBTL1ALDH1A1
SCHEMBL19189841 0.81 MEN1 (0.51) MEN1KMT2AHTTL3MBTL1TOP1
SCHEMBL25798214 0.78 KMT2A (0.52) MEN1KMT2AHTTL3MBTL1TOP1
SCHEMBL15715191 0.78 KMT2A (0.52) MEN1KMT2AHTTL3MBTL1TOP1
SCHEMBL15674146 0.78 MEN1 (0.52) MEN1KMT2AHTTL3MBTL1TOP1
SCHEMBL23658930 0.78 KMT2A (0.52) MEN1KMT2AHTTL3MBTL1TOP1
SCHEMBL20862832 0.78 MEN1 (0.44) MEN1KMT2AHTTL3MBTL1TOP1
SCHEMBL5572022 0.77 KMT2A (0.50) MEN1KMT2AHTTL3MBTL1TOP1
SCHEMBL15711835 0.76 MEN1 (0.47) MEN1KMT2AHTTL3MBTL1TOP1
SCHEMBL28161137 0.74 MEN1 (0.46) MEN1KMT2AHTTTOP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2920189-B1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS BOEHRINGER INGELHEIM INT (DE) 2017-08-02 — — EP disclosed
US-8816112-B2 Process for making novel chiral phosphorus ligands BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-08-26 — — US disclosed
WO-2014078491-A1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-22 — — WO disclosed
US-20140135506-A1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140135506-A1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS PHOSPHO1, INPP5B, PLCG2 MEN1 1250/4885KMT2A 3508/4885HTT 4612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback